Skip to main content
Get Alerts

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 12,181–12,200 of 17,974 drug recalls

Drug Recall Terminated Historical recordClass II

Ertapenem 1 gram Add-Vantage in a) 50 mL and b) 100 mL 0.45% NS bag, FOR IV USE ONLY, Baptist Health Medical Towers Pharmacy & Infusion, Little Rock, AR

by Baptist Health Medical Towers Pharmacy and Infusion Services

Reason
Lack of Sterility Assurance.
Recall initiated
April 18, 2016
Reported by FDA
June 8, 2016
Distribution
Arkansas

View recall →

Drug Recall Terminated Historical recordClass II

Dobutamine 2000 mcg/mL in a) D5W-500 mL, b) D5W-750 mL, c) D5W-1000 mL, d) D5W-1750 mL Bags, FOR IV USE ONLY, Baptist Health Medical Towers Pharmacy & Infusion, Little Rock, AR

by Baptist Health Medical Towers Pharmacy and Infusion Services

Reason
Lack of Sterility Assurance.
Recall initiated
April 18, 2016
Reported by FDA
June 8, 2016
Distribution
Arkansas

View recall →

Drug Recall Terminated Historical recordClass II

Deferoxamine 3300 mg/20 mL Sterile Water for Injection syringe, FOR SUBCUTANEOUS USE ONLY, Baptist Health Medical Towers Pharmacy & Infusion, Little Rock, AR

by Baptist Health Medical Towers Pharmacy and Infusion Services

Reason
Lack of Sterility Assurance
Recall initiated
April 18, 2016
Reported by FDA
June 8, 2016
Distribution
Arkansas

View recall →

Drug Recall Terminated Historical recordClass II

Deferoxamine 4 grams/NS 101 mL Cassette, FOR SUBCUTANEOUS USE ONLY, Baptist Health Medical Towers Pharmacy & Infusion, Little Rock, AR

by Baptist Health Medical Towers Pharmacy and Infusion Services

Reason
Lack of Sterility Assurance
Recall initiated
April 18, 2016
Reported by FDA
June 8, 2016
Distribution
Arkansas

View recall →

Drug Recall Terminated Historical recordClass II

Deferoxamine 2 grams/51 mL NS cassette, FOR SUBCUTANEOUS USE ONLY, Baptist Health Medical Towers Pharmacy & Infusion, Little Rock, AR

by Baptist Health Medical Towers Pharmacy and Infusion Services

Reason
Lack of Sterility Assurance.
Recall initiated
April 18, 2016
Reported by FDA
June 8, 2016
Distribution
Arkansas

View recall →

Drug Recall Terminated Historical recordClass II

Daptomycin 650 mg in 50 mL 0.9% NS bag, FOR IV USE ONLY, Baptist Health Medical Towers Pharmacy & Infusion, Little Rock, AR

by Baptist Health Medical Towers Pharmacy and Infusion Services

Reason
Lack of Sterility Assurance
Recall initiated
April 18, 2016
Reported by FDA
June 8, 2016
Distribution
Arkansas

View recall →

Drug Recall Terminated Historical recordClass II

D5 1/2 NS 1000 mL with Electrolytes bag, FOR IV USE ONLY, Baptist Health Medical Towers Pharmacy & Infusion, Little Rock, AR

by Baptist Health Medical Towers Pharmacy and Infusion Services

Reason
Lack of Sterility Assurance
Recall initiated
April 18, 2016
Reported by FDA
June 8, 2016
Distribution
Arkansas

View recall →

Drug Recall Terminated Historical recordClass II

Clindamycin 900 mg in 100 mL 0.9% NS bag, FOR IV USE ONLY, Baptist Health Medical Towers Pharmacy & Infusion, Little Rock, AR

by Baptist Health Medical Towers Pharmacy and Infusion Services

Reason
Lack of Sterility Assurance
Recall initiated
April 18, 2016
Reported by FDA
June 8, 2016
Distribution
Arkansas

View recall →

Drug Recall Terminated Historical recordClass II

Ceftriaxone 2 gram in 100 mL 0.9% NS bags, FOR IV USE ONLY, Baptist Health Medical Towers Pharmacy & Infusion, Little Rock, AR

by Baptist Health Medical Towers Pharmacy and Infusion Services

Reason
Lack of Sterility Assurance
Recall initiated
April 18, 2016
Reported by FDA
June 8, 2016
Distribution
Arkansas

View recall →

Drug Recall Terminated Historical recordClass II

Ceftriaxone 2 gram Add-Vantage in 100 mL 0.45% NS bag, FOR IV USE ONLY, Baptist Health Medical Towers Pharmacy & Infusion, Little Rock, AR

by Baptist Health Medical Towers Pharmacy and Infusion Services

Reason
Lack of Sterility Assurance
Recall initiated
April 18, 2016
Reported by FDA
June 8, 2016
Distribution
Arkansas

View recall →

Drug Recall Terminated Historical recordClass II

Ceftriaxone 1 gram Add-Vantage in a) 50 mL and b) 100 mL 0.45% NS bags, FOR IV USE ONLY, Baptist Health Medical Towers Pharmacy & Infusion, Little Rock, AR

by Baptist Health Medical Towers Pharmacy and Infusion Services

Reason
Lack of Sterility Assurance
Recall initiated
April 18, 2016
Reported by FDA
June 8, 2016
Distribution
Arkansas

View recall →

Drug Recall Terminated Historical recordClass II

Cefazolin 6 grams in 292 mL 0.9% NS bags, FOR IV USE ONLY, Baptist Health Medical Towers Pharmacy & Infusion, Little Rock, Arkansas

by Baptist Health Medical Towers Pharmacy and Infusion Services

Reason
Lack of Sterility Assurance
Recall initiated
April 18, 2016
Reported by FDA
June 8, 2016
Distribution
Arkansas

View recall →

Drug Recall Terminated Historical recordClass II

Ascorbic Acid 500 mg (1 mL) Syringe, FOR IV USE ONLY, Baptist Health Medical Towers Pharmacy & Infusion, Little Rock, AR

by Baptist Health Medical Towers Pharmacy and Infusion Services

Reason
Lack of Sterility Assurance
Recall initiated
April 18, 2016
Reported by FDA
June 8, 2016
Distribution
Arkansas

View recall →

Drug Recall Terminated Historical recordClass II

70% Ethanol-lock Solution, 2 mL Syringe, FOR IV USE ONLY, Baptist Health Medical Towers Pharmacy & Infusion, Little Rock, AR

by Baptist Health Medical Towers Pharmacy and Infusion Services

Reason
Lack of Sterility Assurance
Recall initiated
April 18, 2016
Reported by FDA
June 8, 2016
Distribution
Arkansas

View recall →

Drug Recall Terminated Historical recordClass II

1/2 Normal Saline 2000 mL + Sodium Acetate 80 mEq., FOR IV USE ONLY, Baptist Health Medical Towers Pharmacy & Infusion, Little Rock, AR

by Baptist Health Medical Towers Pharmacy and Infusion Services

Reason
Lack of Sterility Assurance.
Recall initiated
April 18, 2016
Reported by FDA
June 8, 2016
Distribution
Arkansas

View recall →

Drug Recall Terminated Historical recordClass II

0.9% Sodium Chloride a) 500 mL b) 2000 mL and c) 3000 mL bags, FOR IV USE ONLY, Baptist Health Medical Towers Pharmacy & Infusion, Little Rock, AR

by Baptist Health Medical Towers Pharmacy and Infusion Services

Reason
Lack of Sterility Assurance
Recall initiated
April 18, 2016
Reported by FDA
June 8, 2016
Distribution
Arkansas

View recall →

Drug Recall Ongoing Historical recordClass II

LGD-Xtreme (ligandrol LGD-4033),capsules, 3 mg, 90-count bottle, Manufactured for Continuum Labs, Fort Lauderdale, FL

by Invisiblu International LLC

Reason
Marketed Without An Approved NDA/ANDA: Contains an unapproved drug, ligandrol LGD-4033
Recall initiated
March 31, 2016
Reported by FDA
June 8, 2016
Distribution
Nationwide and Brazil.

View recall →

Drug Recall Terminated Historical recordClass I

SUPER HERBS 350 mg, 30 capsules per bottle.

by Super Herbs

Reason
Marketed without an approved NDA/ANDA - presence of undeclared sibutramine, desmethylsibutramine (an active metabolite of sibutramine) and/or phenolphthalein.
Recall initiated
November 23, 2015
Reported by FDA
June 1, 2016
Distribution
9 consignees - only 9 bottles distributed

View recall →

Drug Recall Terminated Historical recordClass I

Licorice Coughing Liquid (guaifenesin), 5%, 3.38 fl. oz. (100 ml), OTC, Manufactured by: Ma Ying Long Pharmaceutical Group Co., LTD, Wuhan, China; Distributed by: Master Herbs (USA) Inc., NDC 68511-0460-01

by Master Herbs, Inc./Li

Reason
Marketed Without An Approved NDA/ANDA: presence of undeclared morphine.
Recall initiated
January 15, 2016
Reported by FDA
June 1, 2016
Distribution
Nationwide

View recall →

Drug Recall Terminated Historical recordClass I

Zhen Gong Fu, packaged in BIG BOX (16 small boxes / 2 capsules per box / 32 capsules), Distributed by: R Thomas Marketing, LLC, Bronx, NY 10467

by R Thomas Marketing, LLC

Reason
Marketed Without An Approved NDA/ANDA
Recall initiated
January 9, 2016
Reported by FDA
June 1, 2016
Distribution
Nationwide via Internet sales

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.